Ultrasound-Triggered Release of 5-Fluorouracil from Soy Lecithin Echogenic Liposomes

Colorectal cancer is the third most diagnosed cancer and the second leading cause of death. The use of 5-fluorouracil (5-FU) has been the major chemotherapeutic treatment for colorectal cancer patients. However, the efficacy of 5-FU is limited by drug resistance, and bone marrow toxicity through hig...

Descripció completa

Dades bibliogràfiques

Autors principals:	Charles Izuchukwu Ezekiel, Alain Murhimalika Bapolisi, Roderick Bryan Walker, Rui Werner Maçedo Krause
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-06-01
Col·lecció:	Pharmaceutics
Matèries:	colorectal cancer 5-fluorouracil soy lecithin liposomes ultrasound stimuli response
Accés en línia:	https://www.mdpi.com/1999-4923/13/6/821
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!